In vitro toxicity evaluation of lomefloxacin-loaded MCM-41 mesoporous silica nanoparticles

References

• Abou Aitah, K., et al., 2018. Folic acid–conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action. Oncotarget, 9 (41), 26466–26490.
   PubMedGoogle Scholar
• Awaad, A., Nakamura, M., and Ishimura, K., 2012. Imaging of size-dependent uptake and identification of novel pathways in mouse Peyer’s patches using fluorescent organosilica particles. Nanomedicine: Nanotechnology, Biology and Medicine, 8 (5), 627–636.
   PubMed Web of Science ®Google Scholar
• Azad, N., et al., 2013. Reactive oxygen species-mediated p38 MAPK regulates carbon nanotube-induced fibrogenic and angiogenic responses. Nanotoxicology, 7 (2), 157–168.
   PubMed Web of Science ®Google Scholar
• Beberok, A., et al., 2011. Interaction between ciprofloxacin and melanin: The effect on proliferation and melanization in melanocytes. European Journal of Pharmacology, 669 (1–3), 32–37.
   PubMed Web of Science ®Google Scholar
• Beberok, A., et al., 2013. Cytotoxic effect of lomefloxacin in culture of human epidermal melanocytes. Pharmacological Reports, 65 (3), 689–699.
   PubMed Web of Science ®Google Scholar
• Beberok, A., et al., 2015. Impact of sparfloxacin on melanogenesis and antioxidant defense system in normal human melanocytes HEMa-LP – An in vitro study. Pharmacological Reports, 67 (1), 38–43.
   PubMed Web of Science ®Google Scholar
• Benezra, M., et al., 2011. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. Journal of Clinical Investigation, 121 (7), 2768–2780.
   PubMed Web of Science ®Google Scholar
• Brezoiu, A.-M., et al., 2019. Heteroatom modified MCM-41-silica carriers for Lomefloxacin delivery systems. Microporous and Mesoporous Materials, 275, 214–222.
   Web of Science ®Google Scholar
• Cheow, W.S., and Hadinoto, K., 2011. Factors affecting drug encapsulation and stability of lipid–polymer hybrid nanoparticles. Colloids and Surfaces B: Biointerfaces, 85 (2), 214–220.
   PubMed Web of Science ®Google Scholar
• DeMuth, P., et al., 2011. Mesoscale porous silica as drug delivery vehicles: Synthesis, characterization, and pH-sensitive release profiles. Microporous and Mesoporous Materials, 141 (1-3), 128–134.
   Web of Science ®Google Scholar
• European Medicinal Agency, 2018. Fluoroquinolone and quinolone antibiotics: PRAC recommends restrictions on use EMA/668915/2018. available online from: https://www.ema.europa.eu/en/news/fluoroquinolone-quinolone-antibiotics-prac-recommends-new-restrictions-use-following-review.
   Google Scholar
• Evans, B.C., et al., 2013. Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs. Journal of Visualized Experiments: JoVE, (73), 1–5.
   Web of Science ®Google Scholar
• Fujii, M., et al., 2006. Dynamics of photosensitized formation of singlet oxygen by porous silicon in aqueous solution. Journal of Applied Physics, 100 (12), 124302.
   Web of Science ®Google Scholar
• Hagens, W.I., et al., 2007. What do we (need to) know about the kinetic properties of nanoparticles in the body? Regulatory Toxicology and Pharmacology, 49 (3), 217–229.
   PubMed Web of Science ®Google Scholar
• He, Q., et al., 2010. An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles. Biomaterials, 31 (12), 3335–3346.
   PubMed Web of Science ®Google Scholar
• Heikkilä, T., et al., 2010. Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells. European Journal of Pharmaceutics and Biopharmaceutics, 74 (3), 483–494.
   PubMed Web of Science ®Google Scholar
• Horcajada, P., et al., 2006. Influence of superficial organic modification of MCM-41 matrices on drug delivery rate. Solid State Sciences, 8 (10), 1243–1249.
   Web of Science ®Google Scholar
• Hu, Y., et al., 2012. 3D cubic mesoporous silica microsphere as a carrier for poorly soluble drug carvedilol. Microporous and Mesoporous Materials, 147 (1), 94–101.
   Web of Science ®Google Scholar
• ISO 10993, 2009. Biological evaluation of medical devices–Part 5: Tests for in vitro cytotoxicity. Geneva, Switzerland: International Organization for Standardization.
   Google Scholar
• Jones, C.F., and Grainger, D.W., 2009. In vitro assessments of nanomaterial toxicity. Advanced Drug Delivery Reviews, 61 (6), 438–456.
   PubMed Web of Science ®Google Scholar
• Li, Y., 1985. Preparation and controlled release of colon-targeted carboxymethylchitosan microspheres containing levofloxacin: an in vitro study [online], Academic Journal of Second Military Medical University, available from: http://wprim.whocc.org.cn/admin/article/558884
   Google Scholar
• Manzano, M., et al., 2008. Studies on MCM-41 mesoporous silica for drug delivery: effect of particle morphology and amine functionalization. Chemical Engineering Journal, 137 (1), 30–37.
   Web of Science ®Google Scholar
• McEvoy, G. K., 2016. AHFS Drug Information. Bethesda: American Society of Health-System Pharmacists.
   Google Scholar
• Morrison, P.J., et al., 1988. Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses. Antimicrobial Agents and Chemotherapy, 32 (10), 1503–1507.
   PubMed Web of Science ®Google Scholar
• Murugan, B., and Krishnan, U.M., 2018. Chemoresponsive smart mesoporous silica systems – An emerging paradigm for cancer therapy. International Journal of Pharmaceutics, 553 (1–2), 310–326.
   PubMed Web of Science ®Google Scholar
• Narayan, R., et al., 2018. Mesoporous silica nanoparticles: a comprehensive review on synthesis and recent advances. Pharmaceutics, 10 (3), 118.
   PubMed Web of Science ®Google Scholar
• Narkhede, N., et al., 2018. Silica–calix hybrid composite of allyl calix[4]arene covalently linked to MCM-41 nanoparticles for sustained release of doxorubicin into cancer cells. ACS Omega, 3 (1), 229–239.
   PubMed Web of Science ®Google Scholar
• National Research Council; Division on Earth and Life Studies; Board on Environmental Studies and Toxicology; Institute for Laboratory Animal Research; Committee on Toxicity Testing and Assessment of Environmental Agents. 2007. Toxicity Testing in the 21st Century: A Vision and a Strategy. National Academies Press. available from: https://www.nap.edu/read/11970/chapter/2.
   Google Scholar
• Nel, A., et al., 2006. Toxic potential of materials at the nanolevel. Science, 311 (5761), 622–627.
   PubMed Web of Science ®Google Scholar
• Nobuhiko, W., et al., 1990. Phototoxic potential of quinolone antibacterial agents in Balb/c mice. Toxicology Letters, 54 (2–3), 299–308.
   PubMed Web of Science ®Google Scholar
• O'Brien, J., Wilson, I., Orton, T., & Pognan, F., 2000. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. European journal of biochemistry, 267 (17), 5421–5426.
   Google Scholar
• Qian, J., and Ma, Y., 2004. Preparation of levofloxacin-chitosan sustained-release microsphere. Journal-Zhejiang University of Technology, 32 (1), 20–24.
   Google Scholar
• Roberts, R.A., et al., 2006. Role of the kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicological Sciences, 96 (1), 2–15.
   PubMed Web of Science ®Google Scholar
• Sadeek, S.A., and El-Shwiniy, W.H., 2010. Preparation, structure and microbial evaluation of metal complexes of the second generation quinolone antibacterial drug lomefloxacin. Journal of Molecular Structure, 981 (1–3), 130–138.
   Web of Science ®Google Scholar
• Santos, H.A., et al., 2010. In vitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size. Acta Biomaterialia, 6 (7), 2721–2731.
   PubMed Web of Science ®Google Scholar
• Sanzgiri, Y.D., Knaub, S.R., and Riley, C.M., 1994. Lomefloxacin. Analytical Profiles of Drug Substances and Excipients, 23, 321–365.
   Google Scholar
• Sayed, E., et al., 2018. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation. Journal of Controlled Release, 278, 142–155.
   PubMed Web of Science ®Google Scholar
• Shen, H.-L., et al., 2004. Preparation and in vitro release of levofloxacin carboxymethyl chitosan sustained-releasing microsphere. Academic Journal of Second Military Medical University, 5, 005.
   Google Scholar
• Soh, N., 2006. Recent advances in fluorescent probes for the detection of reactive oxygen species. Analytical and Bioanalytical Chemistry, 386 (3), 532–543.
   PubMed Web of Science ®Google Scholar
• Tan, A., et al., 2010. Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems. Molecular Pharmaceutics, 7 (2), 522–532.
   PubMed Web of Science ®Google Scholar
• Tang, F., Li, L., and Chen, D., 2012. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Advanced Materials, 24 (12), 1504–1534.
   PubMed Web of Science ®Google Scholar
• Törnqvist, E., et al., 2014. Strategic focus on 3R principles reveals major reductions in the use of animals in pharmaceutical toxicity testing. Plos One, 9 (7), e101638.
   PubMed Web of Science ®Google Scholar
• Wagai, N., et al., 1989. Studies on experimental conditions for detecting phototoxic potentials of drugs in balb/c mice. The Journal of Toxicological Sciences, 14 (3), 197–204.
   PubMedGoogle Scholar
• Wagai, N., and Tawara, K., 1991. Important role of oxygen metabolites in quinolone antibacterial agent-induced cutaneous phototoxicity in mice. Archives of Toxicology, 65 (6), 495–499.
   PubMed Web of Science ®Google Scholar
• Wagai, N., and Tawara, K., 1992. Possible direct role of reactive oxygens in the cause of cutaneous phototoxicity induced by five quinolones in mice. Archives of Toxicology, 66 (6), 392–397.
   PubMed Web of Science ®Google Scholar
• Wang, X., et al., 2015. Use of a pro-fibrogenic mechanism-based predictive toxicological approach for tiered testing and decision analysis of carbonaceous nanomaterials. ACS Nano, 9 (3), 3032–3043.
   PubMed Web of Science ®Google Scholar
• Williams, G.M., et al., 2013. Relationship of cellular topoisomerase IIα inhibition to cytotoxicity and published genotoxicity of fluoroquinolone antibiotics in V79 cells. Chemico-Biological Interactions, 203 (2), 386–390.
   PubMed Web of Science ®Google Scholar
• Yildirimer, L., et al., 2011. Toxicology and clinical potential of nanoparticles. Nano Today, 6 (6), 585–607.
   PubMed Web of Science ®Google Scholar
• Yuan, L., et al., 2011. Preparation of pH-responsive mesoporous silica nanoparticles and their application in controlled drug delivery. The Journal of Physical Chemistry C, 115 (20), 9926–9932.
   Web of Science ®Google Scholar
• Zhang, Y., Chan, H.F., and Leong, K.W., 2013. Advanced materials and processing for drug delivery: the past and the future. Advanced Drug Delivery Reviews, 65 (1), 104–120.
   PubMed Web of Science ®Google Scholar